Home   ->   news   ->   Press Releases

Press Releases

2016

News Archives: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

2016/08/15
WuXi AppTec’s STA Subsidiary Passed Third U.S. FDA Inspection

2016/08/08
WuXi AppTec’s STA Subsidiary Opens Operations in San Diego

2016/08/01
WuXi AppTec’s Research Service Division Collaborates with Pelago Bioscience to Provide CETSA® based Target Engagement Assays

2016/05/24
The China Precision Medicine Cloud: A world-leading platform to benefit patients and health

2016/05/12
WuXi AppTec’s Pharmaceutical Development Service and Analytical Service Passes EMA Inspection

2016/5/10
WuXi Biologics Congratulates TESARO for Anti-TIM-3 Antibody IND Submission in the U.S..

2016/05/03
WuXi Healthcare Ventures Appoints Renowned Life Science Entrepreneur, Gregory Verdine, Ph.D. as newest Venture Partner

2016/04/15
WuXi AppTec Acquires Crelux

2016/04/11
WuXi AppTec Lab Testing Division’s Analytical and Stability Testing Facilities Passed FDA Inspection

2016/04/08
Juno Therapeutics and WuXi AppTec Announce New Company to Develop Novel Cell-Based Cancer Immunotherapies in China

2016/03/25
WuXi AppTec Launches South Korea Branch

2016/03/25
WuXi Biologics Congratulates Ambrx and ZMC for Successful Dosing of a Novel Antibody-Drug Conjugate in Australia

2016/03/17
Huawei and WuXi AppTec Join Forces to Create China Precision Medicine Cloud Platform

2016/03/10
Simons Foundation and WuXi NextCODE Put World’s Largest Autism Dataset Online to Spur New Era of Massive Genomics Research

2016/03/04
WuXi AppTec’s STA Subsidiary Opens New Campus in Changzhou

2016/03/02
Prima BioMed and WuXi Biologics Announce First Dose of Chinese-Manufactured Biologicin EU Clinical Trial

2016/02/23
WuXi NextCODE Becomes the First and Only CAP, CLIA, and California Accredited Sequencing Laboratory in China

2016/02/15
WuXi AppTec Releases New Mobile App for Compounds Sourcing

2016/02/02
WuXi AppTec Congratulates MSD on Receiving FDA Approval of ZEPATIER™

2016/01/09
WuXi AppTec Plans $120 Million Investment in New Integrated Biologics Solution Center

2016/01/08
WuXi AppTec Congratulates Chia Tai Tianqing Pharmaceutical Group